BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II clinical trial for complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitor that is in Phase I clinical trial to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trial to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of BioCryst Pharmaceuticals Inc..
BioCryst Pharmaceuticals Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of BioCryst Pharmaceuticals Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of BioCryst Pharmaceuticals Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of BioCryst Pharmaceuticals Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of BioCryst Pharmaceuticals Inc. and all latest updates of the company are provided.
The 2025 version of BioCryst Pharmaceuticals Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 BioCryst Pharmaceuticals Inc.- Key Facts
2.2 BioCryst Pharmaceuticals Inc.- Geographic Locations
2.3 BioCryst Pharmaceuticals Inc.- Subsidiaries and Affiliates
2.4 BioCryst Pharmaceuticals Inc.- Business Divisions
2.5 BioCryst Pharmaceuticals Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. BioCryst Pharmaceuticals Inc. Strategic Analysis Review
3.1 BioCryst Pharmaceuticals Inc.- Key Strategies
3.2 BioCryst Pharmaceuticals Inc.- Company Outlook Statement
3.3 BioCryst Pharmaceuticals Inc.- SWOT Analysis
3.3.1 BioCryst Pharmaceuticals Inc.- Key Strengths
3.3.2 BioCryst Pharmaceuticals Inc.- Key Weaknesses
3.3.3 BioCryst Pharmaceuticals Inc.- Potential Opportunities
3.3.4 BioCryst Pharmaceuticals Inc.- Potential Threats
3.4 BioCryst Pharmaceuticals Inc.- Key Competitors
4. Business Description of the Company
4.1 BioCryst Pharmaceuticals Inc.- Business Overview
4.2 BioCryst Pharmaceuticals Inc.- Operations by Segment
5 Products and Services Details
5.1 BioCryst Pharmaceuticals Inc.- Key Products
5.2 BioCryst Pharmaceuticals Inc.- Key Service Areas
5.3 BioCryst Pharmaceuticals Inc.- Key Brands
6 Company Developments
6.1 BioCryst Pharmaceuticals Inc.- Company History
6.2 BioCryst Pharmaceuticals Inc.- Latest Developments
7 Financial Analysis
7.1 BioCryst Pharmaceuticals Inc.- Income Statements
7.2 BioCryst Pharmaceuticals Inc.- Balance Sheet
7.3 BioCryst Pharmaceuticals Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 BioCryst Pharmaceuticals Inc.- Direct Competitors
8.2 BioCryst Pharmaceuticals Inc.- Competitor Financial Ratios comparison
8.3 BioCryst Pharmaceuticals Inc.- Competitor Stock Charts Comparison
8.4 BioCryst Pharmaceuticals Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!